These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3076709)

  • 1. Double-blind dose finding study of mefloquine-sulfadoxine-pyrimethamine in children with acute falciparum malaria.
    Guo XB; Arnold K; Fu LC; Chen PQ; Li GQ
    Trans R Soc Trop Med Hyg; 1988; 82(4):538-40. PubMed ID: 3076709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
    de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB
    Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind studies with mefloquine alone and in combination with sulfadoxine-pyrimethamine in 120 adults and 120 children with falciparum malaria in Vietnam.
    Trinh KA; Nguyen VK; Arnold K; Vo VC; Nguyen NB; Kim T; Ladinsky J
    Trans R Soc Trop Med Hyg; 1990; 84(1):50-3. PubMed ID: 2189246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
    Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
    Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
    Harinasuta T; Bunnag D; Vanijanond S; Charoenlarp P; Suntharasmai P; Chitamas S; Sheth UK; Wernsdorfer WH
    Bull World Health Organ; 1987; 65(3):363-7. PubMed ID: 3311439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.
    Kollaritsch H; Stemberger H; Mailer H; Kremsner P; Kollaritsch R; Leimer R; Wiedermann G
    Trans R Soc Trop Med Hyg; 1988; 82(4):524-9. PubMed ID: 2908258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
    Botero D; Restrepo M; Montoya A
    Bull World Health Organ; 1985; 63(4):731-7. PubMed ID: 3910296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of mefloquine with sulfadoxine-pyrimethamine compared with two sulfadoxine-pyrimethamine combinations in malaria chemoprophylaxis.
    Win K; Thwe Y; Lwin TT; Win K
    Lancet; 1985 Sep; 2(8457):694-5. PubMed ID: 2863679
    [No Abstract]   [Full Text] [Related]  

  • 9. A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria.
    Ekue JM; Simooya OO; Sheth UK; Wernsdorfer WH; Njelesani EK
    Bull World Health Organ; 1985; 63(2):339-43. PubMed ID: 3893778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fansimef [Fansidar plus mefloquine] is effective treatment for imported malaria in New Zealand.
    Ellis-Pegler RB; Beeching NJ; Eales M; Fraser AG; Wells AU
    Aust N Z J Med; 1988 Aug; 18(5):733-4. PubMed ID: 3072955
    [No Abstract]   [Full Text] [Related]  

  • 11. Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria.
    Harinasuta T; Bunnag D; Lasserre R; Leimer R; Vinijanont S
    Lancet; 1985 Apr; 1(8434):885-8. PubMed ID: 2858743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
    Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
    Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance of mefloquine alone and in combination with sulfadoxine-pyrimethamine in the prophylaxis of malaria.
    Reisinger EC; Horstmann RD; Dietrich M
    Trans R Soc Trop Med Hyg; 1989; 83(4):474-7. PubMed ID: 2694482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
    de Souza JM; Sheth UK; de Oliveira RM; Gomes AT; Cavalcante EQ
    Bull World Health Organ; 1985; 63(3):611-5. PubMed ID: 3899398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of a low-dose mefloquine-sulfadoxine-pyrimethamine combination compared with chloroquine in the treatment of acute malaria infection in a population with multiple drug-resistant Plasmodium falciparum.
    Ezedinachi EN; Ekanem OJ; Chukwuani CM; Meremikwu MM; Ojar EA; Alaribe AA; Umotong AB; Haller L
    Am J Trop Med Hyg; 1999 Jul; 61(1):114-9. PubMed ID: 10432067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia.
    Hoffman SL; Rustama D; Dimpudus AJ; Punjabi NH; Campbell JR; Oetomo HS; Marwoto HA; Harun S; Sukri N; Heizmann P
    Lancet; 1985 Nov; 2(8463):1039-40. PubMed ID: 2865518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of Plasmodium falciparum to mefloquine-sulphadoxine-pyrimethamine (Fansimef) in vivo and to mefloquine alone in vitro in Nigeria.
    Salako LA; Aderounmu AF; Laoye JO; Makinde JM; Adio RA
    Ann Trop Med Parasitol; 1988 Aug; 82(4):325-30. PubMed ID: 3075441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malaria chemotherapy trial at a minimal effective dose of mefloquine/sulfadoxine/pyrimethamine compared with equivalent doses of sulfadoxine/pyrimethamine or mefloquine alone.
    Lell B; Lehman LG; Schmidt-Ott JR; Sturchler D; Handschin J; Kremsner PG
    Am J Trop Med Hyg; 1998 May; 58(5):619-24. PubMed ID: 9598451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
    Hengy C; Eberlé F; Gazin P; Kouka-Bemba D; Gelas H; Jambou R
    Bull Soc Pathol Exot; 1990; 83(1):61-5. PubMed ID: 2190706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria.
    Hall AP; Doberstyn EB; Karnchanachetanee C; Samransamruajkit S; Laixuthai B; Pearlman EJ; Lampe RM; Miller CF; Phintuyothin P
    Br Med J; 1977 Jun; 1(6077):1626-8. PubMed ID: 326337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.